A Dana-Farber Cancer Institute stu...
A Dana-Farber Cancer Institute studious mood published in The Lancet plant that cancer patients who record in clinical trials are not better distant from than those who stay with standard treatment. "Comparison of results in cancer patients treated within and outside clinical trials: conceptual framework and
|